Abstract
The spectrum of neuromyelitis optica (NMOSD) includes different phenotypes and serotypes. Understanding disease heterogeneity is fundamental for targeted treatment. We aimed to unravel differences among NMOSD patients using unsupervised machine learning.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
